Stocktoria
NATURAL ALTERNATIVES INTERNATIONAL INC NAII
Nasdaq · XNAS · stock · Medicinal Chemicals & Botanical Products · website · IPO 1997-01-13
NATURAL ALTERNATIVES INTERNATIONAL INC financials (annual, from 10-K)
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | $129.9M | $113.8M | $154.0M | $171.0M | $178.5M |
| Gross profit | $9.3M | $6.9M | $18.2M | $30.5M | $30.4M |
| R&D expense | $1.8M | $1.9M | $2.1M | $2.5M | $1.9M |
| Operating income | -$8.7M | -$8.5M | $4.7M | $13.7M | $13.7M |
| Income tax | $2.8M | -$2.2M | $1.0M | $2.9M | $1.4M |
| Net income | -$13.6M | -$7.2M | $2.5M | $10.7M | $10.8M |
| EPS (diluted) | $-2.28 | $-1.23 | $0.43 | $1.74 | $1.69 |
| Operating cash flow | $5.9M | -$1.5M | $7.0M | $11.9M | $20.8M |
| Free cash flow | $2.3M | -$4.5M | -$6.5M | -$14.6M | $15.7M |
| Cash & equivalents | $12.3M | $12.0M | $13.6M | $21.8M | $32.1M |
| Inventory | $24.9M | $24.2M | $29.7M | $32.5M | $27.0M |
| Total assets | $151.9M | $162.3M | $134.2M | $146.0M | $120.3M |
| Total liabilities | $83.5M | $79.7M | $45.4M | $57.5M | $40.2M |
| Shareholders' equity | $68.4M | $82.6M | $88.8M | $88.5M | $80.1M |
Source: SEC EDGAR filings · CIK 0000787253 · as of 2025-06-30. Facts from filings plus Stocktoria's own computed scores — not investment advice.